✦ LIBER ✦

The Role of Tamoxifen in Treatment of High-Risk, Node-Negative Breast Cancer Patients: Results of a Phase III Intergroup Trial (SWOG 8897, INT-102)1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

11 Lymph node ratio is an independent ri

✍ O. Metzger; E. de Azambuja; E. Quinaux; P. Francis; M. Buyse; J. Crown; M. Ander 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 48 KB

P75 Current status and results of the se

✍ G.J. Schuett; O. Gluz; S. Mohrmann; W. Kuhn; J. Huober; J. Borntr ger; V.M. buss 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 159 KB

P70 The ADEBAR-trial — participation in

✍ J.W. Janni; H. Sommer; B. Rack; D. Steinfeld; D. Augustine; M. Heinrigs; K. Gaug 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 131 KB

A randomized phase III trial of adjuvant

✍ J. Andersen; M. Andersson; K.W. Andersen; P. Dombemowsky; H.T. Mouridsen; C. Ros 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 300 KB

6010 A three-arm phase III randomized tr

✍ Hoff, P.; Clarke, S.; Cunningham, D.; Van Cutsem, E.; Moore, M.; Schmoll, H.J.; 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 48 KB